J. Eric Ahlskog
#129,414
Most Influential Person Now
J. Eric Ahlskog's AcademicInfluence.com Rankings
J. Eric Ahlskogmedical Degrees
Medical
#2119
World Rank
#2519
Historical Rank
Neurology
#203
World Rank
#278
Historical Rank
Download Badge
Medical
Why Is J. Eric Ahlskog Influential?
(Suggest an Edit or Addition)J. Eric Ahlskog's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature (2001) (1318)
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. (2007) (860)
- Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. (2011) (711)
- Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause (2007) (660)
- Pathological gambling caused by drugs used to treat Parkinson disease. (2005) (552)
- Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study (2000) (438)
- Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. (2002) (392)
- Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) (387)
- Pathologic heterogeneity in clinically diagnosed corticobasal degeneration (1999) (372)
- A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease (2007) (367)
- Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism (2003) (356)
- Risk tables for parkinsonism and Parkinson's disease. (2002) (348)
- REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century (2010) (346)
- Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease (2008) (343)
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. (2013) (307)
- Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. (1993) (302)
- Overeating and Obesity from Damage to a Noradrenergic System in the Brain (1973) (299)
- Increased risk of parkinsonism in women who underwent oophorectomy before menopause (2008) (291)
- Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment (1994) (287)
- Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. (2005) (285)
- Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration (2004) (284)
- When does Parkinson disease start? (2010) (270)
- Neuropathology of non-motor features of Parkinson disease. (2009) (243)
- Incidence of dementia with Lewy bodies and Parkinson disease dementia. (2013) (230)
- Early‐onset familial parkinsonism due to POLG mutations (2006) (230)
- Medical records documentation of constipation preceding Parkinson disease (2009) (225)
- Neurologic manifestations in welders with pallidal MRI T1 hyperintensity (2005) (210)
- Stiff-man syndrome and variants: clinical course, treatments, and outcomes. (2012) (209)
- Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. (2006) (207)
- Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study (2001) (207)
- The role of radiotracer imaging in Parkinson disease (2005) (205)
- Time Trends in the Incidence of Parkinson Disease. (2016) (188)
- Imaging correlates of pathology in corticobasal syndrome (2010) (187)
- Smoking, alcohol, and coffee consumption preceding Parkinson’s disease (2000) (181)
- Survival study of Parkinson disease in Olmsted County, Minnesota. (2003) (177)
- Incidental Lewy body disease and preclinical Parkinson disease. (2008) (177)
- Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. (1995) (176)
- Clinical presentation and pharmacological therapy in corticobasal degeneration. (1998) (174)
- Amantadine treatment is an independent predictor of improved survival in Parkinson's disease (1996) (172)
- Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. (1991) (167)
- Superficial siderosis (2006) (164)
- Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease (2008) (162)
- Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. (2007) (157)
- Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. (2009) (156)
- Food intake and amphetamine anorexia after selective forebrain norepinephrine loss. (1974) (154)
- Levodopa‐dyskinesia incidence by age of Parkinson's disease onset (2005) (152)
- Adult-onset opsoclonus-myoclonus syndrome. (2012) (147)
- Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. (2012) (146)
- High school football and risk of neurodegeneration: a community-based study. (2012) (143)
- Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. (2006) (141)
- Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures (2015) (139)
- Levodopa therapy and survival in idiopathic Parkinson's disease (1993) (136)
- Effectiveness of ECT in patients with parkinsonism. (1998) (135)
- Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. (2009) (135)
- Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. (2013) (135)
- Idiopathic intracranial hypertension. (1994) (132)
- Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? (2011) (131)
- Anxious personality predicts an increased risk of Parkinson's disease (2010) (131)
- Hupothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons (1975) (130)
- Rapidly progressive neurodegenerative dementias. (2009) (130)
- Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease. (1988) (128)
- Head trauma preceding PD (2003) (126)
- α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals (2006) (123)
- Imaging features of copper deficiency myelopathy: a study of 25 cases (2006) (119)
- Education and occupations preceding Parkinson disease (2005) (118)
- Acquired hypocupremia after gastric surgery. (2004) (118)
- The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. (1992) (109)
- Myelopathy due to copper deficiency following gastrointestinal surgery. (2003) (108)
- Familial aggregation of Parkinson's disease: The Mayo Clinic family study (2004) (108)
- Clinical features and autonomic testing predict survival in multiple system atrophy. (2015) (107)
- Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study (2006) (104)
- Persistent chorea triggered by hyperglycemic crisis in diabetics (2001) (102)
- The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease (1999) (99)
- Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. (2011) (97)
- Aversive properties of the negative stimulus in a successive discrimination. (1969) (96)
- Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. (2005) (93)
- No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease (1995) (93)
- Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. (2006) (93)
- Slowing Parkinson’s disease progression (2003) (92)
- Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests (2012) (92)
- Risk factors for dementia with Lewy bodies (2013) (89)
- Chemical exposures and Parkinson's disease: A population‐based case–control study (2006) (89)
- Autoimmune chorea in adults (2013) (87)
- Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease (2005) (84)
- Frequency, characteristics, and risk factors for amiodarone neurotoxicity. (2009) (84)
- Autonomic involvement in extrapyramidal and cerebellar disorders (1991) (84)
- Rasagiline, Parkinson neuroprotection, and delayed-start trials (2010) (82)
- Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease (1996) (81)
- Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity (2006) (80)
- Normal pressure hydrocephalus (2011) (80)
- Myelopathy due to copper deficiency (2003) (79)
- Multiple system atrophy: Prognostic indicators of survival (2014) (77)
- Comparative Review of Dopamine Receptor Agonists in Parkinson’s Disease (1996) (76)
- Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy (2019) (74)
- Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study (2016) (74)
- Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. (1990) (73)
- Neuropathology of primary restless leg syndrome: Absence of specific τ‐ and α‐synuclein pathology (2004) (72)
- Decreased catecholamines in the adrenal medulla of patients with parkinsonism. (1988) (72)
- Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults. (2015) (72)
- Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease. (1987) (69)
- Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. (1988) (68)
- Antiphospholipid Antibody-Associated Chorea (2008) (67)
- Decreased adrenal medullary catecholamines in adrenal transplanted parkinsonian patients compared to nephrectomy patients (1989) (66)
- Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease (2007) (66)
- Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease (2011) (65)
- Orthostatic tremor (2016) (65)
- Neuropsychological profiles of manganese neurotoxicity (2006) (63)
- Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia (1998) (63)
- Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance Pathway (2008) (63)
- Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study (2017) (62)
- Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. (2007) (61)
- Posttraumatic cervical dystonia. (1993) (60)
- Risk factors for Parkinson's disease may differ in men and women: an exploratory study (2013) (60)
- Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study (2005) (60)
- The alien limb phenomenon (2013) (59)
- Validity of family history data on PD (2003) (58)
- Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. (1989) (58)
- Utility of an EMG mapping study in treating cervical dystonia (2000) (57)
- Movement Disorders: A Comprehensive Survey (1989) (57)
- Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease. (1999) (57)
- Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology (2013) (57)
- Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. (2003) (56)
- Chorea as a manifestation of spontaneous CSF leak (2006) (56)
- Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study (2012) (55)
- Hemimasticatory spasm (1992) (55)
- Psychogenic tremor: Long term prognosis in patients with electrophysiologically‐confirmed disease (2009) (53)
- Copper deficiency myelopathy. (2004) (52)
- A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease (1998) (50)
- Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. (2009) (50)
- Levodopa-induced dyskinesia in Parkinson disease (2018) (50)
- Guamanian neurodegenerative disease (1995) (49)
- The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy (2012) (49)
- Progressive supranuclear palsy phenotype secondary to CADASIL. (2003) (49)
- Orthostatic myoclonus (2007) (49)
- Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. (1992) (49)
- Hereditary Late-Onset Chorea Without Significant Dementia (1995) (47)
- Interaction of α‐synuclein and tau genotypes in Parkinson's disease (2005) (46)
- Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study (2006) (46)
- Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect. (1996) (45)
- Benign tremulous parkinsonism. (2006) (44)
- Multicenter study of cabergoline, a long‐acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa (1993) (43)
- Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls (2001) (42)
- Movement disorders as sequelae of central pontine myelinolysis: Report of three cases (1992) (42)
- Neurodegenerative diseases of Guam: Analysis of TAU (1999) (42)
- Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. (2017) (42)
- Metabolic markers or conditions preceding Parkinson's disease: A case‐control study (2012) (42)
- Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype (2018) (42)
- Painful legs and moving toes syndrome: a 76-patient case series. (2012) (42)
- Anemia or low hemoglobin levels preceding Parkinson disease (2009) (41)
- The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. (2008) (41)
- Novelty seeking and introversion do not predict the long-term risk of Parkinson disease (2010) (40)
- Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease? (2014) (39)
- Beating a dead horse Dopamine and Parkinson disease (2007) (39)
- Focal shoulder‐elevation dystonia (2000) (38)
- Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. (2007) (38)
- Surgical therapy for tremor in multiple sclerosis (2001) (38)
- Whole-body tremulousness: isolated generalized polymyoclonus. (2007) (38)
- Cerebral transplantation for Parkinson's disease: current progress and future prospects. (1993) (38)
- "Myelodysplasia," myeloneuropathy, and copper deficiency. (2005) (37)
- Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. (2004) (37)
- Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. (2009) (37)
- Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients (1991) (37)
- Cognitive impairment in progressive supranuclear palsy is associated with tau burden (2017) (36)
- Total shoulder arthroplasty in patients with Parkinson's disease. (1996) (36)
- Treatment of Parkinson's disease with pergolide: a double-blind study. (1988) (35)
- Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants (2019) (35)
- SUPERFICIAL SIDEROSIS AND CSF HYPOVOLEMIA: THE DEFECT (DURAL) IN THE LINK (2007) (34)
- Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. (2009) (34)
- Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide) (1992) (34)
- Body weight and regulatory deficits following unilateral nigrostriatal lesions (1977) (33)
- Parkinsonism and dropped head: dystonia, myopathy or both? (2012) (33)
- Selective peripheral denervation for torticollis: preliminary results. (1991) (33)
- UCHL1 is associated with Parkinson's disease: A case-unaffected sibling and case-unrelated control study (2005) (32)
- Beating a dead horse (2007) (31)
- Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions. (2013) (31)
- Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies (2015) (31)
- Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline. (1994) (31)
- The Mayo Clinic Family Study of Parkinson’s Disease: Study Design, Instruments, and Sample Characteristics (2005) (30)
- Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases (1996) (30)
- Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease. (2016) (29)
- Pseudotumor cerebri. (1982) (29)
- Parkinson's disease: medical and surgical treatment. (2001) (29)
- Decreased catecholamine content in parkinsonian adrenal medullae (1989) (28)
- Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota. (1998) (28)
- MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy (2018) (28)
- Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla (1991) (27)
- Parkinson's disease complicated by anxiety. (1987) (27)
- Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. (2005) (27)
- Parkinson's disease and movement disorders : diagnosis and treatment guidelines for the practicing physician (2000) (26)
- Parkinson's Disease Treatment Guide for Physicians (2009) (24)
- Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy. (2018) (24)
- Deep brain stimulation in benign tremulous parkinsonism. (2011) (24)
- Clinical and imaging characterization of progressive spastic dysarthria (2014) (24)
- Treatment of early Parkinson's disease: are complicated strategies justified? (1996) (23)
- Intranasal apomorphine rescue therapy for parkinsonian "off" periods. (1996) (22)
- A limited role for DJ1 in Parkinson disease susceptibility (2004) (22)
- Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? (2011) (22)
- Psychogenic Movement Disorders: Neurology and Neuropsychiatry (2006) (22)
- Drugs for the Treatment of Parkinson's Disease (Handbook of Experimental Pharmacology, Vol 88) (1990) (22)
- Dopamine agonists and Othello's syndrome. (2010) (21)
- Pergolide: long-term use in Parkinson's disease. (1988) (21)
- Clinical Features and Survival of 3R and 4R Tauopathies Presenting as Behavioral Variant Frontotemporal Dementia (2007) (21)
- Feeding response to regulatory challenges after 6-hydroxydopamine injection into the brain noradrenergic pathways (1976) (20)
- Medical treatment of later-stage motor problems of Parkinson disease. (1999) (20)
- Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. (2002) (20)
- Repetitive exercise dystonia: A difficult to treat hazard of runner and non-runner athletes. (2016) (19)
- Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy. (2016) (19)
- Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm (2004) (19)
- The clinical spectrum and natural history of pure akinesia with gait freezing (2016) (19)
- Speech and language disorders associated with corticobasal degeneration (2003) (19)
- Swiss cheese striatum: clinical implications. (2014) (19)
- Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease. (1989) (18)
- Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. (2016) (17)
- Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease (1996) (17)
- Cheaper, simpler, and better: tips for treating seniors with Parkinson disease. (2011) (17)
- Multimodal neuroimaging relationships in progressive supranuclear palsy. (2019) (15)
- Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease (1989) (15)
- Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. (2014) (15)
- Parkinson’s disease: Is the initial treatment established? (2003) (15)
- Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus. (1990) (15)
- Surgical therapy for tremor in multiple sclerosis: An evaluation of outcome measures (2001) (14)
- MRI correlates of alien leg‐like phenomenon in corticobasal degeneration (2005) (14)
- Carbidopa/levodopa for smoking cessation: a pilot study with negative results. (2000) (13)
- Dopaminergic treatment and nonmotor features of Parkinson disease: The horse lives (2013) (13)
- Myelopolyneuropathy due to copper deficiency or zinc excess? (2004) (13)
- Sex and gender influence symptom manifestation and survival in multiple system atrophy (2019) (13)
- Parkinson's Disease Monotherapy With Controlled‐Release MK‐458 (PHNO): Double‐Blind Study and Comparison to Carbidopa/Levodopa (1991) (13)
- Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension (2019) (12)
- Guamanian neurodegenerative disease (1997) (12)
- Number of children and risk of Parkinson's disease (2007) (12)
- PHNO [(+)‐4‐propyl‐9‐hydroxynaphthoxazine] (1988) (11)
- Calf venous compliance in multiple system atrophy. (2007) (10)
- Autonomic failure in Guamanian neurodegenerative disease (1997) (10)
- I can't get no satisfaction (2007) (10)
- Focal brain atrophy in gastric bypass patients with cognitive complaints (2011) (10)
- My Treatment Approach to Multiple System Atrophy. (2021) (10)
- The Parkinson's Disease Treatment Book: Partnering with Your Doctor to Get the Most from Your Medications (2005) (10)
- Violent recurrent ballism associated with infections in two children with static encephalopathy (2000) (10)
- Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone (1997) (9)
- Selegiline and mortality in subjects with Parkinson’s disease: A longitudinal community study (2001) (9)
- Erratum: Comparative review of dopamine receptor agonists in Parkinson's Disease (CNS Drugs 1996 May;5(5):369-88) (1996) (9)
- The Mayo Clinic Cohort Study of Personality and Aging: Design and Sampling, Reliability and Validity of Instruments, and Baseline Description (2006) (9)
- Orthostatic myoclonus associated with Caspr2 antibodies (2016) (8)
- PSYCHOGENIC TREMOR OCCURRING AFTER DEEP BRAIN STIMULATION SURGERY FOR ESSENTIAL TREMOR (2008) (8)
- Diffusion tensor imaging analysis in three progressive supranuclear palsy variants (2021) (8)
- New and Appropriate Goals for Parkinson Disease Physical Therapy. (2016) (8)
- Conjugal multiple system atrophy: Chance, shared risk factors, or evidence of transmissibility? (2019) (7)
- Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy (2021) (7)
- Symptomatic Treatment of Parkinson’s Disease: Levodopa (2004) (6)
- Guamanian neurodegenerative disease: electrophysiologic findings (1999) (6)
- Weight Loss in Parkinson's Disease (1995) (6)
- Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy? (2018) (6)
- December 14, 2009Plenary Session December 14Not your father's Parkinson's disease: non-motor symptoms of PD8:00–10:00 Hall IO.014 Neuropathology of non-motor features of Parkinson disease (2009) (6)
- Hemimasticatory spasm with lateral jaw deviations (2008) (6)
- Approach to the Patient With a Movement Disorder: Basic Principles of Neurologic Diagnosis (2000) (6)
- Earlier age of onset in multiple system atrophy with smoking and heavy alcohol use. (2019) (6)
- Erectile Dysfunction Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study in Olmsted County (2019) (6)
- HSV encephalitis with posterior localization. Author's reply (2004) (6)
- Traumatic brain injury preceding clinically diagnosed α-synucleinopathies (2020) (6)
- Seniors with Parkinson's Disease: Initial Medical Treatment (2010) (6)
- Treatment of Parkinson's disease. (1994) (5)
- Think before you leap (2010) (5)
- Current Trends in the Treatment of Parkinson's Disease (1993) (5)
- Steroid-responsive post-traumatic dystonia: a video case report. (2011) (4)
- Expanding Phenotypic Spectrum of NKX2-1-Related Disorders-Mitochondrial and Immunologic Dysfunction. (2016) (4)
- Natural History of “Pure” Primary Lateral Sclerosis (2021) (4)
- Selective detection and identification of phosphorylated proteins by simultaneous ligand-exchange fluorescence detection and mass spectrometry. (2006) (4)
- Survival and Progression in Synucleinopathy Phenotypes With Parkinsonism: A Population-Based Study. (2019) (4)
- 2-30-01 Clinicopathologic heterogeneity in clinically- and/or pathologically-diagnosed cortical-basal ganglionic degeneration (1997) (4)
- REPLY TO DRS. OLANOW AND RASCOL (2010) (4)
- Parkinson's disease: new treatment strategies. (1990) (4)
- Parkinson's Disease and Movement Disorders (2000) (4)
- Levodopa-induced dyskinesia in dementia with Lewy bodies and Parkinson disease with dementia. (2020) (3)
- Genetic Evidence for a Dual and Opposing Effect of alpha-Synuclein Expression in Preclinical Versus Clinical Parkinson's Disease (IN2-1.003) (2013) (3)
- Initial Symptomatic Treatment of Parkinson’s Disease (2000) (3)
- Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy (2021) (3)
- Infections or Sepsis Preceding Clinically Diagnosed α‐Synucleinopathies: A Case‐Control Study (2020) (3)
- PSP-like syndrome after aortic surgery in adults (Mokri syndrome). (2020) (3)
- Hereditary late-onset chorea without significant dementia: Genetic evidence for substantial phenotypic variation in Huntington’s disease (2019) (3)
- Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine (1983) (3)
- Does levodopa therapy delay death in Parkinson's disease? (1996) (3)
- Corrigendum to "Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies" [Parkinsonism Relat Disord 17 (2011) 260-264] (2011) (3)
- Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study. (1991) (3)
- Central hyperadrenergic state after lightning strike (2013) (2)
- Medication Strategies for Slowing the Progression of Parkinson’s Disease (2000) (2)
- Risk Factors for Dementia with Lewy Bodies (S24.005) (2012) (2)
- Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota. (2022) (2)
- Limb immobilization and corticobasal syndrome. (2012) (2)
- Comparison of DRD2, DRD3 and NMDA Receptor Genotype Polymorphisms in Parkinson's Patients and Controls (IN2-1.007) (2013) (2)
- Clinicopathologic Correlations in 172 Cases of REM Sleep Behavior Disorder ± a Coexisting Neurologic Disorder (PL01.003) (2013) (2)
- JAMA Peer Reviewers in 2018. (2019) (1)
- Medical treatment of Parkinson's disease. (1989) (1)
- Poster 117: Functional Movement Disorders: Successful Treatment Using an Intensive One‐Week Motor Reprogramming Protocol (2010) (1)
- Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? (2022) (1)
- Early-Onset Familial Parkinsonism Due to POLG (2006) (1)
- Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. (2022) (1)
- Adult-Onset Opsoclonus-Myoclonus Syndrome (P04.045) (2012) (1)
- Treatment of Parkinson's disease. From theory to practice. (1994) (1)
- Survival and Risk of Mortality of Clinically-Diagnosed Synucleinopathies: A 15 Year Population-Based Study (1991 - 2005) (P3.350) (2016) (1)
- 1.172 Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson's disease (2007) (1)
- Surgical Treatment of Secondary Tremor (2003) (1)
- Impulse Control Disorders and Dopaminergic Drugs—Reply (2006) (1)
- Dr. Oh and Associates Reply (1992) (1)
- Trimethobenzamide in elderly patients. (2004) (1)
- Incidence of Dementia with Lewy Bodies and Parkinsonism with Dementia (P03.097) (2013) (1)
- Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of Patients. (2020) (1)
- Levodopa and survival (1994) (1)
- Clinical Examinations in Neurology (1957) (1)
- Speech-induced action myoclonus. (2022) (1)
- Lessons for Parkinson disease from the parkin genotype. (2013) (1)
- 2.321 Do chronic non-specific brain insults predispose to incidental Lewy Body Disease? An exploratory study (2007) (0)
- Utility of routine surface electrophysiology to screen for functional tremor prior to surgical treatment of essential tremor (2022) (0)
- Are There Medications for Slowing Disease Progression (2013) (0)
- Book Review (2006) (0)
- OCCUPATIONAL EXPOSURES AND PARKINSON’S DISEASE: A POPULATION-BASED, CASE-CONTROL STUDY (2004) (0)
- Time Trends In The Incidence Of Parkinsonism And Parkinson Disease In Olmsted County, Minnesota Over Thirty Years (S17.007) (2014) (0)
- Prospective Research on Parkinson Nonmotor Symptoms—Reply (2011) (0)
- P1.204 Combined resting–postural tremor – a variant of essential tremor (2009) (0)
- Drug-Induced Compulsive Behaviors: Exceptions to the Rule–Reply–I (2009) (0)
- Manfred D. Muenter, MD (1934–2021) (2021) (0)
- Mayo Clinic office visit. Essential tremor. An interview with J. Eric Ahlskog, M.D., Ph.D. (2010) (0)
- Doubt Cast on Initial Dopamine Agonists for Parkinson Disease (2008) (0)
- α-Synuclein in Red Blood Cells Is a Potential Diagnostic Biomarker for Parkinson’s Disease (1II-2.003) (2014) (0)
- Letters to the editor (1996) (0)
- 1.012 Cardiac sympathetic denervation is early and progressive in Lewy body disease (2007) (0)
- Painful Legs and Moving Toes Syndrome (2015) (0)
- Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies (2022) (0)
- P1.178 Steroid-responsive post-traumatic dystonia: a video case report (2009) (0)
- Adult-Onset Autoimmune Chorea (S08.003) (2012) (0)
- Pearls: parkinsonism. (2010) (0)
- Facial Dyskinesias (Advances in Neurology, Vol 49) (1988) (0)
- Diagnostic steps for suspected Parkinson's disease. (1995) (0)
- P1.187 The Mayo Clinic functional movement disorders protocol: a symptom-based rehabilitation approach (2009) (0)
- Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
- A neurology consultation for Parkinson’s on the psychiatry service (2008) (0)
- Strategies for Reducing Motor Complications: Dyskinesias, Fluctuations (2002) (0)
- A Retrospective Review of the Phenomenon of Gait Freezing (P1.075) (2016) (0)
- Considerations for trials of disease modifying treatments in Parkinson disease (2020) (0)
- Incidence and time trends of drug-induced parkinsonism: a population-based study over 30 years (1976 - 2005) (P1.200) (2015) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- A Comparative Analysis of Autonomic Testing and Diagnostic Consensus Criteria in Autopsy-Confirmed Multiple System Atrophy (P1.262) (2015) (0)
- Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients (I4-4B) (2015) (0)
- Subject Review Cerebral Transplantation for Parkinson's Disease: Current Progress and Future Prospects (1993) (0)
- Early Symptomatic OH and Urinary Incontinence as Diagnostic Clues in MSA (2000) (0)
- Impulse control disorders and dopaminergic drugs. Authors' replay (2006) (0)
- New concepts in the treatment of Parkinson's disease. (1990) (0)
- Clinical Phenotypes of Primary Lateral Sclerosis with Minor Electromyographic Abnormalities (P4.462) (2018) (0)
- with shoulder arthroplasty Parkinson's disease (1997) (0)
- Levodopa-induced dyskinesias in Parkinson disease: a population based-cohort study in Olmsted County, MN (1991–2010) (P2.059) (2018) (0)
- 40-Year incidence of early-onset Parkinson's disease (EOPD) in Southeast Minnesota. (2022) (0)
- Clinical Characteristics and Survival in Multiple System Atrophy (P1.264) (2015) (0)
- Parkinson's Disease (Advances in Neurology, Vol 45), Melvin D. Yahr, Kenneth J. Bergmann (Eds.). Raven Press, New York (1987), 616, with illus, $98.50 (1987) (0)
- Clinical-pathological discrepancies in a population based incidence cohort study on parkinsonism in Olmsted County, MN: 1991–2005 (S22.008) (2017) (0)
- Rem sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century (2011) (0)
- Short communication Progressive supranuclear palsy phenotype secondary to CADASIL (2003) (0)
- Randomized Trial of Rifampicin in MSA: Effect on Autonomic Function (S16.006) (2014) (0)
- MATTERS ARISING (1995) (0)
- JAMA Neurology Peer Reviewers in 2017. (2018) (0)
- Incidence and Distribution of Parkinsonism in Olmsted County Minnesota, 1991-2005 (S42.007) (2012) (0)
- JAMA Neurology Peer Reviewers in 2016. (2017) (0)
- Clinical Phenotypes of Pure Primary Lateral Sclerosis (S31.002) (2018) (0)
- Levodopa, homocysteine and Parkinson's disease: What's the problem? (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With J. Eric Ahlskog?
J. Eric Ahlskog is affiliated with the following schools:
